Corteks proposes to develop a micro-processor controlled self-optimizing amplifier specifically designed to record evoked potentials under adverse conditions. The device will have very high common-mode noise rejection, and markedly reduced susceptibility to stimulus artifact compared to current commercial devices. It is anticipated that these features will make this amplifier better suited for recording evoked potentials in electrically noisy environments, and for performing evoked potential studies which are currently difficult or impossible because of stimulus artifact. In Phase I, n prototype of the amplifier front-end, employing a novel circuit topology, was designed, constructed and tested. The device appears to be largely immune from the effects of stimulus artifact. In Phase II, digital signal processing will be incorporated at a critical point in the circuit to further improve amplifier performance, and automated montage selection techniques will be developed. Portions of the system will be converted to application specific integrated circuits to further improve performance and reduce cost. A prototype of a complete multichannel amplifier, including user interface, will be constructed and tested.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
5R44NS024490-03
Application #
3509176
Study Section
Special Emphasis Panel (SSS (N))
Project Start
1987-05-01
Project End
1991-06-30
Budget Start
1990-07-01
Budget End
1991-06-30
Support Year
3
Fiscal Year
1990
Total Cost
Indirect Cost
Name
Alacron, Inc.
Department
Type
DUNS #
City
Chappaqua
State
NY
Country
United States
Zip Code
10514